3rwdvvlxp 2[dodwh z y · 2021. 1. 21. · 3rwdvvlxp 2[dodwh z y5 ,qjuhglhqwv potassium oxalate 5.0...
TRANSCRIPT
-
Potassium oxalate 5.0 gmDistilled water 100.0 ml
**Formula adjusted, standardized to suit performance parameters
Measure 0.5 ml of this solution into stoppered test tubes. These are dried at room temperature or in an oven at not more
than 60°C. The dry mixture is used so as not to dilute the blood. Place 5 ml blood into this anticoagulated tube and invert
the stoppered tube gently for about 5 times to ensure adequate mixing.
Coagulation of blood can be prevented by various ways, one of them is by adding oxalates. Potassium oxalate shrinks the
red blood cells, whereas ammonium oxalate produces swelling of the cells. When combined as a double oxalate mixture,
they do not affect the shape of the red cells and therefore do not influence the haematocrit. Heparin is an excellent
anticoagulant but is more expensive than other chemicals. Potassium oxalate is commonly used when oxalate is required
since it is more soluble than sodium or lithium salts.
Please refer disclaimer Overleaf.
Intended usePotassium Oxalate, 5% w/v is recommended as anticoagulant of blood for sugar determination.
Type of specimenClinical samples: blood sample
Specimen Collection and Handling1.For clinical samples follow appropriate techniques for handling specimens as per established guidelines( 1,2).
Warning and PrecautionsIn Vitro diagnostic use only. Read the label before opening the container. Wear protective gloves/protective clothing/eye protection/face protection. Follow good microbiological lab practices while handling specimens and culture. Standard precautions as per established guidelines should be followed while handling clinical specimens. Safety guidelines may be referred in individual safety data sheets.
Performance and EvaluationPerformace of the product is expected when used as per the direction on the label within the expiry period when stored atrecommended temperature.
Quality ControlAppearanceColourless liquid.Colourless liquid.
ClarityClear with no insoluble particles.Clear with no insoluble particles.
Concentration4.90%- 5.10%ProcedureMeasure 0.5 ml of the reagent (Potassium oxalate) 0.5% w/v into stoppered test tubes. These are dried at room temperatureor in an oven at not more than 60°C. The dry mixture is used so as not to dilute the blood.Place 5 ml blood intoanticoagulated tube and invert tube gently about 5 times to ensure adequate mixing.Measure 0.5 ml of the reagent (Potassiumoxalate) 0.5% w/v into stoppered test tubes. These are dried at room temperature or in an oven at not more than 60°C. Thedry mixture is used so as not to dilute the blood.Place 5 ml blood into anticoagulated tube and invert tube gently about 5times to ensure adequate mixing.
-
Disclaimer :
User must ensure suitability of the product(s) in their application prior to use. Products conform solely to the information contained inthis and other related HiMedia™ publications. The information contained in this publication is based on our research and developmentwork and is to the best of our knowledge true and accurate. HiMedia™ Laboratories Pvt Ltd reserves the right to make changes tospecifications and information related to the products at any time. Products are not intended for human or animal or therapeutic use butfor laboratory,diagnostic, research or further manufacturing use only, unless otherwise specified. Statements contained herein should notbe considered as a warranty of any kind, expressed or implied, and no liability is accepted for infringement of any patents.
ResultsThe set concentration of Potassium Oxalate keeps the blood uncoagulated.The set concentration of Potassium Oxalate keeps the blood uncoagulated.
Reference
5.Godkar P.B; 1994, Textbook of Medical Laboratory technology ,Bhalani Publication House, Mumbai India.
Revision : 02 / 2019
Technical DataHiMedia Laboratories
DisposalUser must ensure safe disposal by autoclaving and/or incineration of used or unusable preparations of this product. Follow
established laboratory procedures in disposing of infectious materials and material that comes into contact with clinical
sample must be decontaminated and disposed of in accordance with current laboratory techniques (3,4).
In vitro diagnostic
medical device
CE
Marking
Do not use if package is damaged HiMedia Laboratories Pvt.
Limited, B /4-6 , MIDC,
Dindori, Nashik MH
www.himedialabs.com
CE Partner 4U ,Esdoornlaan
13, 3951 DB Maarn The
Netherlands,
www.cepartner 4u.eu
IVD
Storage temperature10°
C
30°C
EC REP
HiMedia Laboratories Pvt. Ltd. Reg.office : 23, Vadhani Ind.Est., LBS Marg, Mumbai-400086, India. Customer care No.: 022-6116 9797 Corporate office : A-516,Swastik Disha Business Park,Via Vadhani Ind. Est., LBS Marg, Mumbai-400086, India. Customer care No.: 022-6147 1919 Email: [email protected] Website: www.himedialabs.com
Gaby, W. L., and L. Free. 1958. Differential diagnosis of pseudomonas-like microorganisms in the clinical laboratory. J.Bateriol. 76:442–444. 2. Gaby, W. L., and C. Hadley. 1957. Practical laboratory test for the identification of Pseudomonas aeruginosa. J. Bacteriol.74:356–358.
1.
3. Lapage S., Shelton J. and Mitchell T., 1970, Methods in Microbiology', Norris J. and Ribbons D., (Eds.), Vol. 3A, AcademicPress, London.4.MacFaddin J. F., 2000, Biochemical Tests for Identification of Medical Bacteria, 3rd Ed., Lippincott, Williams and Wilkins,Baltimore.
Storage and Shelf LifeStore between 10-30°C in tightly closed container and away from bright light. Use before expiry date on label. On opening, product should be properly stored in dry ventilated area protected from extremes of temperature and sources of ignition. Seal the container tightly after use.
Blank Page